Neutralization of feline immunodeficiency virus by polyclonal feline antibody: Simultaneous involvement of hypervariable regions 4 and 5 of the surface glycoprotein

Journal of Virology

Volumn 69, Issue 8, 1995, Pages 5124-5127

  Siebelink, Kees H J ^a   Huisman, Willem ^a   Karlas, J A ^a   Rimmelzwaan, Guus F ^a   Bosch, Marnix L ^b   Osterhaus, Albert D M E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; FELINE IMMUNODEFICIENCY VIRUS; NOTE; PEPTIDE MAPPING; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS NEUTRALIZATION;

EID: 0029042301     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.69.8.5124-5127.1995     Document Type: Note

References (28)

1. Ackley, C. D., J. K. Yamamoto, N. Levy, N. C. Pedersen, and M. D. Cooper. 1990. Immunologie abnormalities in pathogen-free cats experimentally infected with feline immunodeficiency virus. J. Virol. 64:5652-5655.
2. Alexander, S., and J. H. Elder. 1984. Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. Science 226: 1328-1330.
3. Baldinotti, F., D. Matteucci, P. Mazzetti, C. Giannelli, P. Bandecchi, F. Tozzini, and M. Bendinelli. 1994. Serum neutralization of feline immunodeficiency virus is markedly dependent on passage history of the virus and host system. J. Virol. 68:4572-4579.
4. Barlough, J. E., C. D. Ackley, J. W. George, N. Levy, R. Acevedo, P. F. Moore, B. A. Rideout, M. D. Cooper, and N. C. Pedersen. 1991. Acquired immune dysfunction in cats with experimentally induced feline immunodeficiency virus infection: comparison of short-term and long-term infections. J. Acquired Immune Defic. Syndr. 4:219-227.
5. Bosch, M. L., A. C. Andeweg, R. Schipper, and M. Kenter. 1994. Insertion of N-linked glycosylation sites in the variable regions of the human immunodeficiency virus type 1 surface glycoprotein through AAT triplet reiteration. J. Virol. 68:7566-7569.
6. Davis, D., D. M. Stephens, C. Willers, and P. J. Lachmann. 1990. Glycosylation governs the binding of antipeptide antibodies to regions of hypervariable amino acid sequence within recombinant gp120 of human immunodeficiency virus type 1. J. Gen. Virol. 71:2889-2898.
7. De Ronde, A., J. G. Stam, P. Boers, H. Langedijk, R. Meloen, W. Hesselink, L. C. E. J. M. Keldermans, A. van Vliet, E. J. Verschoor, M. C. Horzinek, and H. F. Egberink. 1994. Antibody response in cats to the envelope proteins of feline immunodeficiency virus: identification of an immunodominant neutralization domain. Virology 198:257-264.
8. Dow, S. W., M. L. Poss, and E. A. Hoover. 1990. Feline immunodeficiency virus: a neurotropic lentivirus. J. Acquired Immune Defic. Syndr. 3:658-668.
9. Haigwood, N. L., P. L. Nara, E. Brooks, G. A. Van Nest, G. Ott, K. W. Higgins, N. Dunlop, C. J. Scandella, J. W. Eichberg, and K. S. Steimer. 1992. Native but not denatured recombinant human immunodeficiency virus type 1 gp120 generates broad-spectrum neutralizing antibodies in baboons. J. Virol. 66:172-182.
10. Hansen, J.-E. S., H. Clausen, C. Nielsen, L. S. Teglbjærg, L. L. Hansen, C. M. Nielsen, E. Dabelsteen, L. Mathiesen, S.-I. Hakomori, and J. O. Nielsen. 1990. Inhibition of human immunodeficiency virus (HIV) infection in vitro by anticarbohydrate monoclonal antibodies: peripheral glycosylation of HIV envelope glycoprotein gp120 may be a target for virus neutralization. J. Virol. 64:2833-2840.
11. + cell numbers in cats with naturally acquired feline immunodeficiency virus infection. J. Virol. 66:1484-1488.
12. Hurtrel, M., J.-P. Ganière, J.-F. Guelfi, L. Chakrabarti, M.-A. Maire, F. Gray, L. Montagnier, and B. Hurtrel. 1992. Comparison of early and late feline immunodeficiency virus encephalopathies. AIDS 6:399-406.
13. Klasse, P. J., J. A. McKeating, M. Schutten, M. S. Reitz, Jr., and M. Robert-Guroff. 1993. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582 (→ Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site. Virology 192:332-337.
14. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
15. Lombardi, S., C. Garcelli, C. LaRosa, L. Zaccaro, S. Specter, G. Malvaldi, F. Tozzini, F. Esposito, and M. Bendinelli. 1993. Identification of a linear neutralization site within the third variable region of feline immunodeficiency virus envelope. J. Virol. 67:4742-4749.
16. McKeating, J. A., J. Gow, J. Goudsmit, L. H. Pearl, C. Mulder, and R. A. Weiss. 1989. Characterization of HIV-1 neutralization escape mutants. AIDS 3:777-784.
17. Pancino, G., I. Fossati, C. Chappey, S. Castelot, B. Hurtrel, A. Moraillon, D. Klatzman, and P. Sonigo. 1993. Structure and variations of feline immunodeficiency virus envelope glycoproteins. Virology 192:659-662.
18. Pedersen, N. C., E. W. Ho, M. L. Brown, and J. K. Yamamoto. 1987. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science 235:790-793.
19. Shelton, G. H., M. L. Linenberger, C. K. Grant, and J. L. Abkowitz. 1990. Hematologic manifestations of feline immunodeficiency virus infection. Blood 76:1104-1109.
20. Siebelink, K. H. J., M. L. Bosch, G. F. Rimmelzwaan, R. H. Meloen, and A. D. M. E. Osterhaus. 1995. Two different mutations in the envelope protein of feline immunodeficiency virus allow the virus to escape from neutralization by feline serum antibodies. Vet. Immunol. Immunopathol. 46:51-59.
21. Siebelink, K. H. J., I. Chu, G. F. Rimmelzwaan, K. Weijer, A. D. M. E. Osterhaus, and M. L. Bosch. 1992. Isolation and partial characterization of infectious molecular clones of feline immunodeficiency virus obtained directly from bone marrow DNA of a naturally infected cat. J. Virol. 66:1091-1097.
22. Siebelink, K. H. J., I. Chu, G. F. Rimmelzwaan, K. Weijer, R. van Herwijnen, P. Knell, H. F. Egberink, M. L. Bosch, and A. D. M. E. Osterhaus. 1990. Feline immunodeficiency virus (FIV) infection in the cat as a model for HIV infection in man: FIV-induced impairment of immune function. AIDS Res. Hum. Retroviruses 6:1373-1378.
23. Siebelink, K. H. J., G. F. Rimmelzwaan, M. L. Bosch, R. H. Meloen, and A. D. M. E. Osterhaus. 1993. A single amino acid substitution in hypervariable region 5 of the envelope protein of feline immunodeficiency virus allows escape from virus neutralization. J. Virol. 67:2202-2208.
24. Sodora, D. L., E. G. Sphaer, B. E. Kitchell, S. W. Dow, E. A. Hoover, and J. I. Mullins. 1994. Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J. Virol. 68:2230-2238.
25. Sparger, E. E., P. A. Luciw, J. H. Elder, J. K. Yamamoto, L. J. Lowenstine, and N. C. Pedersen. 1989. Feline immunodeficiency virus is a lentivirus associated with an AIDS-like disease in cats. AIDS 3:S42-S49.
26. Tozzini, F., D. Matteucci, P. Bandecchi, F. Baldinotti, K. Siebelink, A. Osterhaus, and M. Bendinelli. 1993. Neutralizing antibodies in cats infected with feline immunodeficiency virus. J. Clin. Microbiol. 31:1626-1629.
27. Wilson, C., M. S. Reite, Jr., K. Aldrich, P. J. Klasse, J. Blomberg, R. C. Gallo, and M. Robert-Guroff. 1990. The site of an immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 does not constitute the neutralization epitope. J. Virol. 64:3240-3248.
28. Yamamoto, J. K., E. Sparger, E. W. Ho, P. R. Andersen, T. P. O'Connor, C. P. Mandell, L. Lowenstine, R. Munn, and N. C. Pedersen. 1988. Pathogenesis of experimentally induced feline immunodeficiency virus infection in cats. Am. J. Vet. Res. 49:1246-1258.